BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3093192)

  • 1. Ovine prolactin (PRL) and dopamine preferentially inhibit PRL release from the same subpopulation of rat mammotropes.
    Frawley LS; Clark CL
    Endocrinology; 1986 Oct; 119(4):1462-6. PubMed ID: 3093192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.
    Luque EH; Munoz de Toro M; Smith PF; Neill JD
    Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay.
    Neill JD; Frawley LS
    Endocrinology; 1983 Mar; 112(3):1135-7. PubMed ID: 6401620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional variations among prolactin cells from different pituitary regions.
    Boockfor FR; Frawley LS
    Endocrinology; 1987 Mar; 120(3):874-9. PubMed ID: 3100286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release of prolactin by thyrotropin-releasing hormone: influence of dopamine, thyroxine, and cycloheximide.
    Turpen C; Knigge KM
    Horm Res; 1979; 11(3):128-41. PubMed ID: 114468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF; Liu TC
    J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the effects of catecholestrogens on prolactin secretion by cultured normal rat anterior pituitary cells.
    Lamberts SW; Verleun T; Oosterom R
    Endocrinology; 1985 Jun; 116(6):2631-6. PubMed ID: 2986958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suckling unmasks the stimulatory effect of dopamine on prolactin release: possible role for alpha-melanocyte-stimulating hormone as a mammotrope responsiveness factor.
    Hill JB; Nagy GM; Frawley LS
    Endocrinology; 1991 Aug; 129(2):843-7. PubMed ID: 1649748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV; Wang W; Grosvenor CE; Crowley WR
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dopamine on thyrotropin-releasing hormone-induced prolactin secretion in vitro.
    Fagin KD; Neill JD
    Endocrinology; 1981 Dec; 109(6):1835-40. PubMed ID: 6796383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine.
    Cui ZJ; Gorelick FS; Dannies PS
    Endocrinology; 1994 May; 134(5):2245-50. PubMed ID: 8156928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP; Nguyen DN; Smith SG; Freeman ME
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid augmentation of prolactin cell number and secretory capacity by an estrogen-induced factor released from the neurointermediate lobe.
    Ellerkmann E; Nagy GM; Frawley LS
    Endocrinology; 1991 Aug; 129(2):838-42. PubMed ID: 1906805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium ions: their role and mechanism of action in the control of prolactin release.
    Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
    Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J; Ciofi P; Crowley WR
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.